GW Pharmaceuticals Plc Analysis
GW Pharmaceuticals Plc is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of GW Pharmaceuticals delisted stock analysis is to determine its intrinsic value, which is an estimate of what GW Pharmaceuticals Plc is worth, separate from its market price. There are two main types of GW Pharmaceuticals' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect GW Pharmaceuticals' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of GW Pharmaceuticals' stock to identify patterns and trends that may indicate its future price movements.
The GW Pharmaceuticals stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. GW Pharmaceuticals is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. GWPH Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and GW Pharmaceuticals' ongoing operational relationships across important fundamental and technical indicators.
GWPH |
GWPH Stock Analysis Notes
About 80.0% of the company shares are owned by institutional investors. The company has Price/Earnings (P/E) ratio of 126.7. GW Pharmaceuticals Plc recorded a loss per share of 1.86. The entity had not issued any dividends in recent years. GW Pharmaceuticals plc, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid product platform in various disease areas. GW Pharmaceuticals plc was founded in 1998 and is based in Cambridge, the United Kingdom. Gw Pharma operates under Drug ManufacturersGeneral classification in the United States and is traded on NASDAQ Exchange. It employs 1161 people. To learn more about GW Pharmaceuticals Plc call Justin Gover at (44) 1223 235667 or check out www.gwpharm.com.GW Pharmaceuticals Plc Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. GW Pharmaceuticals' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding GW Pharmaceuticals Plc or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| GW Pharmaceuticals is not yet fully synchronised with the market data | |
| GW Pharmaceuticals has some characteristics of a very speculative penny stock | |
| GW Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 527.2 M. Net Loss for the year was (58.13 M) with profit before overhead, payroll, taxes, and interest of 489.67 M. | |
| GW Pharmaceuticals Plc currently holds about 486.75 M in cash with (27.39 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 15.53. | |
| Over 80.0% of the company shares are owned by institutional investors |
GW Pharmaceuticals Thematic Classifications
In addition to having GW Pharmaceuticals stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | MarijuanaEntities with exposure to distribution of Marijuana |
GWPH Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 6.81 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate GW Pharmaceuticals's market, we take the total number of its shares issued and multiply it by GW Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.GWPH Profitablity
GW Pharmaceuticals' profitability indicators refer to fundamental financial ratios that showcase GW Pharmaceuticals' ability to generate income relative to its revenue or operating costs. If, let's say, GW Pharmaceuticals is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, GW Pharmaceuticals' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of GW Pharmaceuticals' profitability requires more research than a typical breakdown of GW Pharmaceuticals' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (11.03) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (9.82) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $9.82.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding GW Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Global Markets Map Now
Global Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
| All Next | Launch Module |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in GWPH Stock
If you are still planning to invest in GW Pharmaceuticals Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the GW Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |